Department of Pediatric Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom.
Pediatric Neurology and Muscle Disease Unit, Istituto Giannina Gaslini, Genova, Italy.
Pediatr Pulmonol. 2018 Oct;53(10):1414-1421. doi: 10.1002/ppul.24122. Epub 2018 Jul 10.
Obstructive sleep apnoea (OSAS) in children with Down syndrome (DS) is now well recognized, but other forms of sleep disordered breathing (SDB) in this population are less well described. Anecdotally, respiratory support for SDB treatment in this population is not easily tolerated. We aimed to characterize the types of SDB in children with DS referred to a tertiary respiratory center and to assess the effectiveness and adherence to respiratory support.
Retrospective study of DS patients <18 years old under follow-up at a tertiary respiratory center. Anthropometrics, comorbidities, sleep study results, and details of respiratory support were collected. Satisfactory adherence to oxygen (O ), Continuous Positive Airway Pressure (CPAP), or bilevel noninvasive ventilation (NIV) was defined as use >4 h/night for >50% nights.
Sixty patients were included, median age 1.5 (0.7-5.3) years; 49 (82%) had congenital heart disease, 16 (27%) pulmonary hypertension, 28 (47%) gastroesophageal reflux, 38 (63%) swallowing impairment; 16/17 who underwent CT scanning had evidence of aspiration. Forty-two had SDB: 27 (61%) OSAS (10 mild, 5 moderate, 12 severe), 11 (25%) central apnoeas, 19 (32%) nocturnal hypoventilation. Twenty-six had baseline saturations <95%. Lower SpO correlated with pulmonary hypertension (r = 0.1, P = 0.04). Thirty-nine (65%) patients started respiratory support (14 O , 18 CPAP, 7 NIV) and 22 (56%) have regularly used it. After a 1.9 years follow up 11/24 had satisfactory adherence to CPAP/NIV (average use 8 h/night).
Our results confirm the high prevalence of OSAS in children with DS. A significant number also have low baseline saturations, central apnoeas, and nocturnal hypoventilation. Contrary to popular belief, more than half of children with DS had satisfactory adherence to respiratory support.
阻塞性睡眠呼吸暂停(OSAS)在唐氏综合征(DS)儿童中已得到广泛认识,但该人群中其他形式的睡眠呼吸障碍(SDB)描述较少。据报道,该人群的 SDB 治疗的呼吸支持不易耐受。我们旨在描述转诊至三级呼吸中心的 DS 儿童的 SDB 类型,并评估呼吸支持的有效性和依从性。
对在三级呼吸中心接受随访的 <18 岁 DS 患者进行回顾性研究。收集人体测量学、合并症、睡眠研究结果和呼吸支持的详细信息。氧(O )、持续气道正压通气(CPAP)或双水平无创通气(NIV)的满意依从性定义为每晚使用>4 小时且>50%的夜间。
共纳入 60 例患者,中位年龄为 1.5(0.7-5.3)岁;49 例(82%)患有先天性心脏病,16 例(27%)患有肺动脉高压,28 例(47%)患有胃食管反流,38 例(63%)存在吞咽障碍;17 例接受 CT 扫描的患者中,16 例有吸入证据。42 例存在 SDB:27 例(61%)为 OSAS(10 例轻度,5 例中度,12 例重度),11 例(25%)为中枢性呼吸暂停,19 例(32%)为夜间低通气。26 例基线饱和度<95%。较低的 SpO 与肺动脉高压相关(r=0.1,P=0.04)。39 例(65%)患者开始使用呼吸支持(14 例 O ,18 例 CPAP,7 例 NIV),22 例(56%)定期使用。经过 1.9 年的随访,11/24 例 CPAP/NIV 具有良好的依从性(平均使用 8 小时/夜)。
我们的结果证实 DS 儿童 OSAS 的高患病率。有相当数量的患者还存在基线饱和度低、中枢性呼吸暂停和夜间低通气。与普遍看法相反,超过一半的 DS 儿童对呼吸支持具有良好的依从性。